Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The present study aims to determine frequency of thromboembolic complications and the underlying causes of this complication of the patients who admitted to the intensive care unit diagnosed with COVID-19.
Patients diagnosed with COVID-19 infection and admitted to the ICU were recruited. Demographic information, comorbidities, length of ICU stay, some laboratory data,thromboembolic complications of the patients were recorded.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Ancestral variant | Ancestral variant is the first subtype of SARS CoV-2 virus which is the agent of first COVID-19 infection in Wuhan. Thromboembolic complications of this group were detected among patients which were infected with ancestral variant of COVID-19 | ||
| Delta Variant | Delta variant is the subtype of SARS CoV-2 virus which is first COVID-19 subtype identified in India. Thromboembolic complications of this group were detected among patients which were infected with delta variant of COVID-19 | ||
| Alpha variant | Alpha variant is the subtype of SARS CoV-2 virus which is first identified COVID-19 subtype in United Kingdom. Thromboembolic complications of this group were detected among patients which were infected with alpha variant of COVID-19 | ||
| Other variants | Other variants is the subtype of SARS CoV-2 virus which were identified in Brazil, South Africa..etc. Thromboembolic complications of this group were detected among patients which were infected with alpha variant of COVID-19 |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Rate of thromboembolic complications among patients who effected from different variants of COVID-19 Disease | Both arterial and venous thromboembolic events were detected | During the entire intensive care stay up to 1 day |
| Measure | Description | Time Frame |
|---|---|---|
| Rate of thromboembolic complications of COVID-19 disease in critically ill patients | Both arterial and venous thromboembolic events were detected | During the entire intensive care stay up to 1 day |
| Rate of thromboembolic complications according to anticoagulant therapy |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Study Population of the present study is all of the patients diagnosed with COVID-19 and admitted to the intensive care units at Derince Training and Research Hospital at the time of between 1-March-2020 and 31-December-2021in
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Berna Karakoyun Lacin, Prof. | Health and Science University Hamidiye Institute of Health Sciences | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Derince Research and Training Hospital | Kocaeli | Derince | 41900 | Turkey (Türkiye) |
Not provided
| ID | Term |
|---|---|
| D000086382 | COVID-19 |
| D013923 | Thromboembolism |
| ID | Term |
|---|---|
| D011024 | Pneumonia, Viral |
| D011014 | Pneumonia |
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
Not provided
Not provided
Not provided
Not provided
Not provided
Antithrombotic therapy of each patient was recorded |
| During the entire intensive care stay up to 1 day |
| What is the rate of thromboembolism according to the comorbidities | Comorbidities of each patient were recorded from the patients records. | During the entire intensive care stay up to 1 day |
| D014777 |
| Virus Diseases |
| D018352 | Coronavirus Infections |
| D003333 | Coronaviridae Infections |
| D030341 | Nidovirales Infections |
| D012327 | RNA Virus Infections |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D016769 | Embolism and Thrombosis |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |